# Nantahala Capital Management LLC

Type: Company

Source: Healthcare Intelligence Brief — https://gethealthbrief.com/entity/nantahala-capital-management-llc
Canonical HTML page: https://gethealthbrief.com/entity/nantahala-capital-management-llc

## Recent coverage (1 stories)

### Renuvion Maker Apyx Drops 1.8% to $4.38 Despite Q1 Revenue Beat
2026-08-13 02:42:20 · Sentiment: Neutral · Impact: 5/10 · Sources: 2

For healthcare and medical device stakeholders, Apyx Medical's Q1 revenue of $12.49 million beat consensus by $1.96 million, yet the stock fell 1.8% to $4.38. The decline on 60% below-average volume suggests limited conviction, while analysts maintain a moderate buy rating and $6.50 target. The company's strong liquidity ratios contrast with its negative net margin and return on equity.
Full story: https://gethealthbrief.com/story/apyx-medical-revenue-beat-stock-drop-health

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://gethealthbrief.com/guides/methodology for the full editorial methodology.